MDCO

The Medicines Company Press Releases

$24.55
*  
0.35
 negative 
1.41%
Get MDCO Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Medicines Company and Certain Officers - MDCO
4/18/2014 1:28:00 PM - Market Wire

Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
4/10/2014 12:30:00 PM - PR Newswire

The Medicines Company to Announce First Quarter 2014 Financial Results on Wednesday, April 23, 2014
4/9/2014 10:09:00 AM - Market Wire

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in The Medicines Company of Class Action Lawsuit and Upcoming Deadline -- MDCO
4/7/2014 4:00:00 AM - GlobeNewswire

Study Results, Stock Price Movements, Product Launches, and Updates on Court Case Trials - Analyst Notes on Medtronic, Alexion, DaVita, Thermo Fisher Scientific, and Medicines
4/4/2014 8:00:00 AM - PR Newswire

FDA Accepts the Filing of The Medicines Company's US Biologic License Application for Fibrocaps Hemostatic Agent
4/3/2014 7:00:00 AM - Market Wire

Update on Angiomax(R) (Bivalirudin) Patent Litigation
3/31/2014 9:36:00 PM - Market Wire

Analysis of EUROMAX and HORIZONS-AMI Trials of The Medicines Company's Angiomax(R) (Bivalirudin) Presented at ACC.14
3/30/2014 11:30:00 AM - Market Wire

SHAREHOLDERS ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Medicines Company and Certain Officers - MDCO
3/21/2014 4:48:00 PM - PR Newswire

The Medicines Company Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors
3/18/2014 3:35:00 PM - Business Wire

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in The Medicines Company to Contact the Firm
3/15/2014 3:10:00 PM - Market Wire

Cohen Milstein Sellers & Toll PLLC Announces the Investigation of The Medicines Company
3/14/2014 10:24:00 AM - Business Wire

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in The Medicines Company of Class Action Lawsuit and Upcoming Deadline -- MDCO
3/7/2014 5:53:00 PM - GlobeNewswire

The Medicines Company to Participate in 2014 Barclays Global Healthcare Conference
3/6/2014 11:19:00 AM - Market Wire

Attention The Medicines Company Investors: The Medicines Company Misled Investors According to a Recently Filed Class Action
3/3/2014 3:19:00 PM - PR Newswire

European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company's Oritavancin
2/27/2014 8:43:00 AM - Market Wire

Lifshitz & Miller Law Firm Announces Investigation of Emeritus Corporation, Nu Skin Enterprises, Inc., The Medicines Company, Thoratec Corporation and TriQuint Semiconductor, Inc.
2/26/2014 10:50:00 AM - PR Newswire

THE MEDICINES COMPANY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $150,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Medicines Company -- MDCO
2/25/2014 10:00:00 PM - GlobeNewswire

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against The Medicines Company
2/24/2014 7:15:00 PM - PR Newswire

Pomerantz Law Firm Announces the Filing of a Class Action Against The Medicines Company and Certain Officers -- MDCO
2/21/2014 5:48:00 PM - GlobeNewswire

The Medicines Company to Participate in Upcoming Healthcare Investor Conferences
2/19/2014 4:36:00 PM - Market Wire

The Medicines Company Reports Fourth Quarter and Full Year 2013 Financial Results
2/19/2014 7:00:00 AM - Market Wire

FDA Accepts Filing of the Medicines Company's New Drug Application for Intravenous Antibiotic Oritavancin With Priority Review
2/19/2014 6:30:00 AM - Market Wire

Intercept Expands Its Board of Directors With Appointments of Sanj K. Patel and Glenn Sblendorio
2/18/2014 6:50:00 AM - GlobeNewswire

THE MEDICINES COMPANY SHAREHOLDERS NOTICE: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Certain Officers and Directors of The Medicines Company
2/13/2014 1:03:00 PM - Business Wire